MDMA and Other Hallucinogen Use: Onset and Abuse/Dependence
MDMA 和其他致幻剂的使用:发作和滥用/依赖性
基本信息
- 批准号:7416698
- 负责人:
- 金额:$ 14.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAlcoholsAntisocial Personality DisorderAnxiety DisordersChronicComorbidityConditionCrack CocaineDataData AnalysesDatabasesDependenceDiseaseDrug abuseDrug usageEpidemiologyHallucinogensHealthHeroinHouseholdIncidenceInjection of therapeutic agentInterventionLocationLongitudinal StudiesMental disordersMethamphetamineMoodsNatural HistoryOnset of illnessPatternPersonal CommunicationPopulationPrevalencePrevention programPrimary PreventionResearch PersonnelRiskSamplingScoreServicesSex CharacteristicsSpecific qualifier valueSubgroupSubstance Use DisorderSubstance abuse problemSurveysagedalcohol use disordercostecstasyprogramstrend
项目摘要
DESCRIPTION (provided by applicant): This revised R01 application, proposed by a new investigator, requests 3 years of support to study gender differences in the epidemiology of MDMA (Ecstasy) and other hallucinogen use. We propose to conduct secondary data analyses of existing data: the 2001-2004 National Surveys on Drug Use and Health (NSDUH) and the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). We will examine four specific aims. The first aim is to examine gender differences in the incidence and determinants of first use of MDMA and other hallucinogens, including incidence trends, risk periods for initiation, and correlates of recent initiation. The second aim is to determine gender differences in the pattern, sequence, and correlates of multi-drug use among hallucinogen users, including injection drug use (IDU) and use of methamphetamine, cocaine/crack, and heroin. The third aim is to examine gender differences in the natural history of hallucinogen use disorders and correlates of hallucinogen use disorders, including the progression from first use to disorder onset, to onsets of other substance use disorders, and temporal associations with mental disorders. The fourth aim is to investigate gender differences in the prevalence, patterns, and correlates of substance abuse treatment service use among hallucinogen users, including the location of services received, the primary abused substance for receiving treatment, and perceived unmet needs for and barriers to treatment use. Our proposed analysis will help identify the heightened risk periods for initiation and demographic subgroups at risk for using MDMA and other hallucinogens to facilitate targeting primary prevention programs. The findings also will specify subgroups of MDMA/hallucinogen users who have an increased likelihood of IDU, multidrug use, drug abuse or dependence, and other mental disorders, so they can be targeted for focused programs or interventions to reduce serious consequences of chronic MDMA and other drug abuse. We will understand better the pattern of, unmet needs for, and barriers to substance abuse service use among MDMA/hallucinogen users. Given the extremely high cost of a sophisticated longitudinal study, our proposed secondary analysis of already collected data is an initial and cost-effective step to study the distributions, correlates, courses, consequences, and treatment use of hallucinogen users.
描述(由申请人提供):由一名新研究者提出的修订后的R 01申请要求3年的支持,以研究MDMA(摇头丸)和其他致幻剂使用流行病学中的性别差异。 我们建议对现有数据进行二级数据分析:2001-2004年全国药物使用和健康调查(NSDUH)和全国酒精和相关疾病流行病学调查(NESARC)。我们将研究四个具体目标。第一个目的是研究首次使用摇头丸和其他致幻剂的发生率和决定因素的性别差异,包括发生率趋势、开始使用的风险期和最近开始使用的相关因素。第二个目的是确定致幻剂使用者中多种药物使用的模式、顺序和相关性的性别差异,包括注射药物使用(IDU)和甲基苯丙胺、可卡因/快克和海洛因的使用。第三个目的是研究致幻剂使用障碍的自然史和致幻剂使用障碍的相关性的性别差异,包括从第一次使用到障碍发作的进展,到其他物质使用障碍的发作,以及与精神障碍的时间关联。第四个目的是调查致幻剂使用者中药物滥用治疗服务使用的流行率、模式和相关性的性别差异,包括接受服务的地点、接受治疗的主要滥用药物以及认为未满足的治疗需求和障碍。我们提出的分析将有助于确定启动的高风险期和使用MDMA和其他致幻剂的风险人口统计学亚组,以促进针对初级预防计划。研究结果还将详细说明MDMA/致幻剂使用者的亚组,这些亚组的IDU,多药使用,药物滥用或依赖以及其他精神障碍的可能性增加,因此他们可以成为重点项目或干预措施的目标,以减少慢性MDMA和其他药物滥用的严重后果。我们将更好地了解MDMA/致幻剂使用者使用药物滥用服务的模式、未满足的需求和障碍。鉴于一个复杂的纵向研究的成本极高,我们提出的二次分析已经收集的数据是一个初步的和具有成本效益的步骤,研究的分布,相关性,课程,后果和治疗使用的致幻剂用户。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Li-Tzy Wu其他文献
Li-Tzy Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Li-Tzy Wu', 18)}}的其他基金
Increasing access to opioid use disorder treatment by opening pharmacy-based medication units of opioid treatment programs
通过开设阿片类药物治疗项目的药房用药单位,增加获得阿片类药物使用障碍治疗的机会
- 批准号:
10679104 - 财政年份:2022
- 资助金额:
$ 14.52万 - 项目类别:
The impact of chronic pain on buprenorphine treatment retention among patients with opioid use disorder.
慢性疼痛对阿片类药物使用障碍患者丁丙诺啡治疗保留的影响。
- 批准号:
10202541 - 财政年份:2020
- 资助金额:
$ 14.52万 - 项目类别:
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind
药物滥用
- 批准号:
8476963 - 财政年份:2013
- 资助金额:
$ 14.52万 - 项目类别:
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind
药物滥用
- 批准号:
8695479 - 财政年份:2013
- 资助金额:
$ 14.52万 - 项目类别:
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind
药物滥用
- 批准号:
9213315 - 财政年份:2013
- 资助金额:
$ 14.52万 - 项目类别:
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind
药物滥用
- 批准号:
8795113 - 财政年份:2013
- 资助金额:
$ 14.52万 - 项目类别:
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies
物质使用严重程度和治疗结果的分类:NIDA CTN 研究
- 批准号:
8053547 - 财政年份:2009
- 资助金额:
$ 14.52万 - 项目类别:
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies
物质使用严重程度和治疗结果的分类:NIDA CTN 研究
- 批准号:
8133990 - 财政年份:2009
- 资助金额:
$ 14.52万 - 项目类别:
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies
物质使用严重程度和治疗结果的分类:NIDA CTN 研究
- 批准号:
7762506 - 财政年份:2009
- 资助金额:
$ 14.52万 - 项目类别:
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies
物质使用严重程度和治疗结果的分类:NIDA CTN 研究
- 批准号:
8311820 - 财政年份:2009
- 资助金额:
$ 14.52万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 14.52万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 14.52万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 14.52万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 14.52万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 14.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 14.52万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 14.52万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 14.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 14.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 14.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




